Answer: Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications that includes semaglutide (Wegovy, Ozempic, Rybelsus), tirzepatide (Zepbound, Mounjaro), liraglutide (Victoza, Saxenda), and orforglipron (Foundayo), have become increasingly popular for obesity treatment (Mehrtash, JAMA Intern Med 2025)
Your dose may need to go up over weeks or months, but your price won'ta transparent alternative to dose-ladder pricing common elsewhere
Key Takeaways Fundamentally different mechanisms: CJC-1295/Ipamorelin stimulate the pituitary to produce endogenous GH, while HGH (somatropin) introduces exogenous growth hormone directly Pituitary feedback preserved vs
Ravi specializes in advanced body contouring procedures, including his signature SMART Tummy Tuck
Diet-microbiota Interactions as Moderators of Human Metabolism